Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection (Q46273075)

21 December 2017

title

Interplay between SAFE and RISK pathways in sphingosine-1-phosphate-induced cardioprotection (English)

1 reference

21 December 2017

4

Lionel H Opie

1 reference

21 December 2017

Sarin J Somers

1

1 reference

21 December 2017

Miguel Frias

series ordinal

2

1 reference

21 December 2017

Lydia Lacerda

series ordinal

3

1 reference

21 December 2017

Sandrine Lecour

series ordinal

5

1 reference

21 December 2017

publication date

1 June 2012

1 reference

21 December 2017

Cardiovascular Drugs and Therapy

published in

1 reference

21 December 2017

volume

26

1 reference

21 December 2017

page(s)

227-237

1 reference

21 December 2017

issue

3

1 reference

21 December 2017

HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Sphingosine 1-phosphate levels in plasma and HDL are altered in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Combined sphingosine, S1P and ischemic postconditioning rescue the heart after protracted ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Interaction of sphingosine 1-phosphate with plasma components, including lipoproteins, regulates the lipid receptor-mediated actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Quantitative analysis of sphingoid base-1-phosphates as bisacetylated derivatives by liquid chromatography-tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Sphingosine 1-phosphate induces contraction of coronary artery smooth muscle cells via S1P2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Sphingosine 1-phosphate (S1P) receptor subtypes S1P1 and S1P3, respectively, regulate lymphocyte recirculation and heart rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Mechanisms of cardioprotection by lysophospholipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

TNFalpha in atherosclerosis, myocardial ischemia/reperfusion and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Sphingosine kinase and sphingosine 1-phosphate in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Sphingosine 1-phosphate S1P2 and S1P3 receptor-mediated Akt activation protects against in vivo myocardial ischemia-reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Ethanolamine is a novel STAT-3 dependent cardioprotective agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

The myocardial JAK/STAT pathway: from protection to failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Function of mitochondrial Stat3 in cellular respiration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

TNFα protects cardiac mitochondria independently of its cell surface receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Foxo transcription factors blunt cardiac hypertrophy by inhibiting calcineurin signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Expression of the longevity proteins by both red and white wines and their cardioprotective components, resveratrol, tyrosol, and hydroxytyrosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Silent information regulator 1 protects the heart from ischemia/reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

FoxO transcription factors promote cardiomyocyte survival upon induction of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

STAT3α interacts with nuclear GSK3beta and cytoplasmic RISK pathway and stabilizes rhythm in the anoxic-reoxygenated embryonic heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

JAK/STAT signaling is associated with cardiac dysfunction during ischemia and reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Can the protective actions of JAK-STAT in the heart be exploited therapeutically? Parsing the regulation of interleukin-6-type cytokine signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

Ischemic postconditioning in pigs: no causal role for RISK activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6376-2

10.1007/S10557-012-6376-2

21 January 2018

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

22392184

1 reference

21 December 2017